Modeling neurodegeneration in Caenorhabditiselegans

Kim A. Caldwell, Corey W. Willicott, Guy A. Caldwell

Drug discovery: Insights from the invertebrate Caenorhabditis elegans

Giunti S, Andersen N, Rayes D, De Rosa MJ.

Caenorhabditis elegans for rare disease modeling and drug discovery: strategies and strengths

Peter A. Kropp, Rosemary Bauer, Isabella Zafra, Carina Graham, Andy Golden

Editorial: C. elegans as an emerging model of pharmacological innovation

Huang Z, Ma L, Mishra A, Turnbull JE, Tu H.